Arkolith/Insider Trading/GLUE/Form 4

Warmuth Markus

President & CEO, DirectorMonte Rosa Therapeutics, Inc. (GLUE) · full profile →Form 4 · filed Jun 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$106K
Net Open-Market Flow
-$106K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 1, 2026Sell(S)5K$19.41$97K595K
Jun 1, 2026Sell(S)468$19.73$9K595K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-253472) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML